These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4575610)

  • 21. Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma.
    Heinzerling LM; Urbanek M; Funk JO; Peker S; Bleck O; Neuber K; Burg G; von Den Driesch P; Dummer R
    Cancer; 2000 Oct; 89(8):1835-44. PubMed ID: 11042581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Histomorphological and histochemical changes in affected skin of patients with primary reticulosis and reticulosarcomatosis of the skin].
    Sych LI; Kalamkarian AA; Mukhamedov N
    Vestn Dermatol Venerol; 1974 Oct; 0(10):3-8. PubMed ID: 4611087
    [No Abstract]   [Full Text] [Related]  

  • 23. [Application of prospidin in the treatment of patients with cancer of the larynx].
    Pogosov VS; Chernov VA; Antoiv VF
    Vestn Otorinolaringol; 1970; 32(1):57-61. PubMed ID: 5448717
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evolution of histopathologic changes and clinical manifestations in primary reticulosis of the skin].
    Kodolova IM; Potekaev NS
    Arkh Patol; 1971; 33(8):55-61. PubMed ID: 4945624
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin's lymphoma.
    Colovic N; Jurisic V; Terzic T; Atkinson HD; Colovic M
    Arch Dermatol Res; 2009 Oct; 301(9):689-92. PubMed ID: 19495780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relapse of diffuse large B cell lymphoma to CD20-negative multiple cutaneous tumors immediately after anti-CD20 monoclonal antibody (rituximab) therapy].
    Iguchi T; Miyazawa K; Okabe S; Kawakubo K; Shimamoto T; Kuriyama Y; Ito Y; Kimura Y; Ohyashiki K; Serizawa H; Iwaya K; Mukai K
    Rinsho Ketsueki; 2004 Oct; 45(10):1129-34. PubMed ID: 15553050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy in reticulum-cell sarcoma in five dogs and a cat and in mast-cell leukemia in a cat.
    McClelland RB
    Cornell Vet; 1971 Jul; 61(3):477-81. PubMed ID: 4936153
    [No Abstract]   [Full Text] [Related]  

  • 28. [Case report on cutaneous reticulo-endotheliosis].
    Sandri R
    Minerva Med; 1973 Mar; 64(13):623-8. PubMed ID: 4695152
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical evaluation of the antitumor effectiveness of spirobromine].
    Borisov VI; Chernov VA; Dement'eva NP; Korobkova LI; Bogdanova NV
    Sov Med; 1987; (12):42-3. PubMed ID: 3445176
    [No Abstract]   [Full Text] [Related]  

  • 30. [Very late malignant transformation of papullar reticulosis with a prolonged development (lymphomatoid papulosis)].
    Dupont A
    Ann Dermatol Syphiligr (Paris); 1973; 100(2):141-6. PubMed ID: 4578545
    [No Abstract]   [Full Text] [Related]  

  • 31. Imatinib mesylate in the treatment of a large unresectable dermatofibrosarcoma protuberans: a case study.
    Savoia P; Ortoncelli M; Quaglino P; Bernengo MG
    Dermatol Surg; 2006 Aug; 32(8):1097-102. PubMed ID: 16918576
    [No Abstract]   [Full Text] [Related]  

  • 32. [Polymorphic reticulosis of the rhinopharynx].
    Ariza Toledo MA; Sierra Galera G; García Teno M; Báez JM; Roquette Gaona J; Bartual Pastor J
    An Otorrinolaringol Ibero Am; 1999; 26(4):359-66. PubMed ID: 10520275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary cutaneous large B-cell lymphoma, leg type, successfully treated with rituximab plus chemotherapy.
    Posada García C; Florez A; Pardavila R; Garcia-Cruz A; Amador L; Alvarez M; Alberte LM; Cruces MJ
    Eur J Dermatol; 2009; 19(4):394-5. PubMed ID: 19467966
    [No Abstract]   [Full Text] [Related]  

  • 34. Woringer-Kolopp (localized pagetoid reticulosis) treated with topical photodynamic therapy (PDT).
    Berroeta L; Lewis-Jones MS; Evans AT; Ibbotson SH
    Clin Exp Dermatol; 2005 Jul; 30(4):446-7. PubMed ID: 15953099
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cytostatics and immunosuppressive agents in dermatology].
    Braun-Falco O; Burg G
    Hautarzt; 1970 Sep; 21(9):391-7. PubMed ID: 4937654
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab.
    Grange F; Maubec E; Bagot M; Beylot-Barry M; Joly P; Dalle S; Delaporte E; Dereure O; Bachelez H; Vergier B; Petrella T; D'Incan M
    Arch Dermatol; 2009 Mar; 145(3):329-30. PubMed ID: 19289772
    [No Abstract]   [Full Text] [Related]  

  • 37. Vinblastine treatment of malignant lymphomas.
    Klener P; Donner L; Neuwirtová R; Ort J
    Neoplasma; 1971; 18(5):505-11. PubMed ID: 4940935
    [No Abstract]   [Full Text] [Related]  

  • 38. [Secondary tumors in hemoblastoses during cytostatic treatment].
    Hartwich G; Butzler W
    Med Klin; 1971 Oct; 66(43):1445-50. PubMed ID: 5001553
    [No Abstract]   [Full Text] [Related]  

  • 39. Rituximab in diffuse large B-cell lymphoma.
    Coiffier B
    Clin Adv Hematol Oncol; 2004 Mar; 2(3):156-7. PubMed ID: 16166943
    [No Abstract]   [Full Text] [Related]  

  • 40. [Contribution to the study of Pautrier and Woringer lipomelanic reticulosis].
    Coppolino A; La Rosa P
    G Ital Dermatol Minerva Dermatol; 1968; 109(5):399-406. PubMed ID: 4308139
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.